LabTrac™

PAH Pathways Interactive Resource Locator

PAH Pathways offers a wealth of resources including one-on-one support from PAH Pathways counselors in your area.
Learn more »

A program that lets your doctor track your lab results online

To save your doctor valuable time and paperwork, PAH Pathways offers a special program to select offices called LabTrac. Your healthcare provider may be participating in LabTrac, a program that allows for the easy review of laboratory results associated with treatment on Tracleer

Tracleer is indicated for patients with pulmonary arterial hypertension (PAH) WHO Class II-IV.

Tracleer Important Safety Information

Because of the risks associated with Tracleer, this medication may be prescribed only by your doctor through the Tracleer Access Program. Liver damage: Tracleer can cause serious liver damage, including in rare cases liver failure and, in situations with regular liver testing, unexplained liver cirrhosis. So you must have a blood test to check your liver function before you start Tracleer and each month after that. Call your doctor right away if you have any of these symptoms of liver problems: nausea, vomiting, fever, unusual tiredness, abdominal (stomach area) pain, or yellowing of the skin or whites of your eyes (jaundice). Serious birth defects: Tracleer is very likely to cause serious birth defects. It is important not to be or to become pregnant while taking Tracleer and to have a pregnancy test before you start the drug and each month thereafter. It is very important for you to use reliable forms of birth control while taking Tracleer. Hormonal contraceptives should not be used alone because they may not be effective in patients taking Tracleer.

Do not take Tracleer with glyburide or cyclosporine-A, because they may increase your chance for side effects.

Please see full Prescribing Information, including BOXED WARNING and Medication Guide.

Ventavis

For full Prescribing Information for Ventavis click here.